A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

BY AMAYA NICHOLE, NEWS WRITER

Eli Lilly headquarters in Indianapolis, Indiana. Photo: Getty Images

For millions of people who have struggled with weight loss, a new experimental drug from Eli Lilly may present the most promising option yet.

Today, the pharmaceutical company announced the results from a recent clinical trial, dubbed........

© Inc.com